By Julie Steenhuysen CHICAGO, Aug 19 (Reuters) – Moderna's mRNA vaccine combined with Merck's immunotherapy Keytruda succeeded in a late-stage trial for skin cancer, the companies said on Wednesday,
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Ronaldinho to return to action with Italian club Ravenna
VIDEO SHOWS: ARCHIVE VIDEO OF RONALDINHO RAVENNA FC PRESIDENT IGNAZIO CIPRIANI RESENDING WITH COMPLETE SHOTLIST…
Bo Nix, Broncos bring sputtering offense to face Cardinals
The Denver Broncos survived a challenging early schedule with three signature wins and their only…
OpenAI resumes frontier AI training after security overhaul, discloses flaw in widely used software
Oct 23 (Reuters) - OpenAI said on Friday it had resumed training of its most…
